Nuveen New York Select Tax-Free Income Portfolio
NXN · NYSE
2/28/2025 | 2/29/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | -$0 | $0 |
| % Growth | 33.4% | 441.4% | -126.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 100% | 90.9% | 132.7% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | -$0 | $0 |
| % Margin | 89.9% | 180% | 801.1% | 87.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 71.7% | 179.9% | 801.2% | -17.1% |
| EPS | 0.4 | 0.76 | -0.99 | -0.08 |
| % Growth | -47.4% | 176.8% | -1,132.9% | – |
| EPS Diluted | 0.4 | 0.76 | -0.99 | -0.08 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$0 | $0 | -$0 | -$0 |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 0% | 179.9% | 801.1% | 0% |